Fundamental value investor that understands and utilizes technical entry and exits to add value. 15 years experience as an investor. Specializing in Energy Sector, Value Strategies, Hedge Fund Long/Short Equity Strategies, Small and Mid Capitalization stocks.
Follow me on StockTwits: http://stocktwits.com/LSValue
Follow me on Twitter: https://twitter.com/LSValue
I‘m an economics undergraduate student of the Rheinische Friedrich-Wilhelms-Universität Bonn.
I got into investing at age 17 after reading the intelligent investor and other books about Warren Buffet.
This is a pseudonym. Started my career in structured finance, moved into corporate debt, and now equities. My investment style is focus on the fundamentals and figure out what the company is worth. Writing is a way for me to gather feedback and information, rather than convincing someone else to buy or sell. Please feel free to message me. thanks
With 30 years of investing experience, Strong Bio strives to identify highly undervalued biotechnology with clear publically disclosed scientific support in the form of peer reviewed journal articles or data analysis-driven open clinical studies.
Four private female investors and one Dachshund.
We've consigned our careers as fund managers to the shredder, as we no longer have confidence that we can grow our clients' money anywhere near approaching the sparkling results that we achieved for them in the past.
Now Heidi and Desiree's investing interests involve global water distribution, agriculture, and timberland, while Clarissa and Helga manage strategies of certain commodities and hard assets.
We're also self-styled asset-manager vigilantes, who will bitch-slap those who take advantage of innocent retirees and other retail investors who have been ground into muesli by the Wall Street machine.
Sleazy RIA's, CFA's and 99% of the rest of financial "helpers" service their clients like Bonny and Clyde serviced banks.
As you can see, we're touchy, emotional, irascible, opinionated, and sometimes inebriated. But we admit that we do love the attention here on SA, so don't stop sending us those bawdy comments, angry criticisms, steamy love letters, veiled death threats, and tempting marriage proposals. Hey, you never know...
Oh, we almost forgot... While our names (Heidi, Helga, Clarissa and Desiree) may or may not be our real names, Schnitzel the Dachshund's name really is "Schnitzel the Dachshund."
Lateral Capital Management, Inc. (“LCMI”) is a long/short credit & equity fund focussed on the infrastructure, mining & resources, oil & gas, renewables and utility sectors primarily in North America.
Follow us @lateralcapital on Twitter
Having always been a learning machine, I speak five languages, have worked as a sales agent, project manager, translator, computer consultant, software engineer, built a house with my own hands, published books and essays on literature, philosophy and art, have written for magazines of various kinds in different countries.
After retiring early in 2004, little by little, I have become a fund manager for some friends and myself, following the principles of value investing laid out by Benjamin Graham, Phil Fisher, Charlie Munger and Warren Buffett. You can read about my thoughts on a suitable portfolio structure for early retirees here.
My articles should not be considered to be any kind of investment advice. What suits me well is not necessarily good for others, as successful investing is somewhat like a marriage: If only one is perfect, the marriage won’t work. So please do your own research and remember Benjamin Graham's advice: “The investor’s chief problem — and even his worst enemy — is likely to be himself.”
I run a very concentrated portfolio with 10-15 positions and invest for the long term. As of 12/2016, my largest position is Theravance Biopharma (TBPH), a company I had intensively and extensively researched long before any sell-side analyst noticed the stock. You can find my early work on TBPH on this site and my comprehensive in-depth research reports on all important pipeline assets here. I correctly predicted the evolution of the new GOLD guidelines for COPD, the sales trajectory of Vibativ and GSK's new Ellipta product range. My reports have been far ahead (in terms of depth, scope and reliability) of all sell-side work on TBPH. That said, I obviously make mistakes as well, although I've yet to make one that costs me serious money.
Other long-time favorites of mine are DaVita (DVA), IBM and a few European small caps which I have also partly covered on Seeking Alpha, e.g. Admiral (AMIGF), Fuchs Petrolub (FUPEF).
Andrew Walker, CFA, is a portfolio manager at Rangeley Capital LLC with a focus on small cap special situations investments. Mr. Walker also contributes to Sifting the World, a value investing forum.
Over 6 years' experience on the buyside. Spent nearly 3 years of my professional career as a Research Analyst investing in public markets (stocks) and the other 2 in the private arena (VC/growth equity and distressed/restructurings). I am a highly passionate investor and always consider both the macroeconomic backdrop coupled with in-depth fundamental research to identify the best investment ideas, which are generally contrarian, value-biased, opportunistic or event-driven.
I specialize in understanding the dynamics that underlie and drive investment performance in today's global financial markets, despite a muddling of views among regulators and investors alike in the new, free money era. Following the global financial crisis, expansionary monetary policies of unprecedented magnitude implemented by major central banks across the globe (primarily those of the so called "core economies") have completely redefined the ways in which the global markets operate. I am not your typical hedge fund or money manager who stamps a disclaimer on investment performance with the assertion that "we are bottom-up, fundamental equity investors" who "do not attempt to forecast the markets." I go far beyond this basic, fundamental analysis and offer unique foresight into major anticipated (equity and credit) market movements BEFORE they materialize.
I have a with a knack for identifying under- and over-valued positions and a strong understanding of macroeconomics. I constantly analyze and evaluate central bank policies globally as well as global trade conditions. I have unique experience particular to sectors such as energy (both conventional and non-conventional), agriculture, infrastructure and real assets (industrials, real estate, water infrastructure, roads/railways, etc.), in addition to chemicals and consumer products; however, I've been a generalist research analyst for the majority of my career to date. Options are a trading mechanism of choice, particularly when I have visible catalysts for near-term price appreciation (or depreciation in the case of puts). I also utilize options strategies to earn large profits with limited downside risk.
George Soros is founder and chair of Soros Fund Management LLC and the Open Society Foundations. Born in Budapest in 1930, he survived the Nazi occupation during World War II and fled communist-dominated Hungary in 1947 for England, where he graduated from the London School of Economics. He then settled in the United States, where he accumulated a large fortune through the international investment fund he founded and managed. Soros has been active as a philanthropist since 1979, when he began providing funds to help black students attend Cape Town University in apartheid South Africa. The Open Society Foundations today operate in more than 100 countries, with annual expenditures that reached $835 million in 2011, working to promote the values of open society, human rights, and transparency. Soros is the author of over a dozen books, including The Tragedy of the European Union: Disintegration or Revival? (2014). His articles and essays on politics, society, and economics regularly appear in major newspapers and magazines around the world.
Doug Short is first-wave boomer with a lifelong interest in markets and the economy. His professional career had been a satisfying split between academia (English Professor at North Carolina State University) and Information technology (IBM and GSK).
Doug retired in 2006 to devote himself full-time to his dshort.com financial website. The domain has now been acquired by Advisor Perspectives, and Doug has been appointed the Vice President of Research.
Doug is especially interested in the economy, long-term market trends and behavioral finance.
Whitney Tilson is the founder and Managing Partner of Kase Capital Management, which manages three value-oriented hedge funds. Mr. Tilson is also the co-founder of Value Investor Insight, an investment newsletter.
Mr. Tilson has co-authored two books, The Art of Value Investing: How the World's Best Investors Beat the Market (2013) and More Mortgage Meltdown: 6 Ways to Profit in These Bad Times (2009), was one of the authors of Poor Charlie’s Almanack, the definitive book on Berkshire Hathaway Vice Chairman Charlie Munger, and has written for Forbes, the Financial Times, Kiplinger’s, the Motley Fool and TheStreet.com. He was featured in two 60 Minutes segments in December 2008 about the housing crisis (which won an Emmy) and in March 2015 about Lumber Liquidators. He served for two years on the Board of Directors of Cutter & Buck, which designs and markets upscale sportswear, until the company was sold in early 2007.
Mr. Tilson received an MBA with High Distinction from the Harvard Business School, where he was elected a Baker Scholar (top 5% of class), and graduated magna cum laude from Harvard College, with a bachelor’s degree in Government.
Mr. Tilson spent much of his childhood in Tanzania and Nicaragua (his parents are both educators, were among the first couples to meet and marry in the Peace Corps, and have retired in Kenya). Consequently, Mr. Tilson is involved with a number of charities focused on education reform and Africa. For his philanthropic work, he received the 2008 John C. Whitehead Social Enterprise Award from the Harvard Business School Club of Greater New York. He is a member and past Chairman of the Manhattan chapter of the Young Presidents’ Organization. Mr. Tilson lives in Manhattan with his wife and three teenage daughters.
John Huber is the portfolio manager of Saber Capital Management, LLC, an investment firm that manages separate accounts for clients. Saber employs a value investing strategy with a primary goal of patiently compounding capital for the long-term.
John also writes about investing at the blog www.basehitinvesting.com, and can be reached at email@example.com.
Shreya has experience with and exposure to the financial industry through her previous roles and internships at various firms.
She has passed Level II of the CFA exam.
Her writings focus on long value investments, portfolio strategy, and small-cap investments. She is also interested in options strategies.
Note: Shreya Mathur is NOT a registered investment advisor and investors should perform their own research and due diligence before investing.
I am the founder of MarketEyewitness.com, a financial blog that I started in August 2012. On this blog, we research equities, industries and other economic indicators. Currently, Market Eyewitness is geared towards covering futuristic trends such as 3DPrinting, Robotics, Internet of Things and Social Media.
I graduated magna cum laude from the Zarb School of Business at Hofstra University with an undergraduate degree in finance. I received my MBA from the Binghamton University School of Management in August 2013.
You can follow me at my New Twitter handle: http://www.twitter.com/write4lyfe or at my blog's Twitter handle: https://twitter.com/MKTEyewitness.
You can also check out my Google+ page = https://plus.google.com/u/0/+AndreWaldronatMarketEyewitness/posts
The writer is a long term value investor and M.Sc graduate in Financial Markets with over 10 years experience. Value can be found in both long and short ideas and uses options to enhance the risk-return profile of investment ideas.
Disclaimer: This article provides opinions and information, but does not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research or obtain suitable personal advice.
Jordan S. Terry is the Founder & Managing Director of Stone Street Advisors LLC. He has a BS in finance with minor coursework in engineering & entrepreneurship from Penn State, and an MBA from NYU Stern School of Business with concentrations in corporate finance and business law. He has work experience in corporate development, investment banking, operations, and investment research. His investing/analysis experience spans more than 10 years across virtually all industries and sectors. He has written about business, technology, innovation, policy and finance (both theory and practice) as well as industry- and firm-specific analysis since 2005.
In 2011, Jordan founded Stone Street Advisors LLC, an investment research and consulting firm catering to investment funds and corporations. Stone Street's track record of picking both long and short ideas has significantly outperformed the S&P500 on both a absolute and relative basis (detailed information available upon request).
He has written fairly extensively for The Atlantic, Forbes (where he has a column, "Fundamentally Speaking"), Zerohedge, Business Insider and other popular outlets, and his work has been highlighted by FT, WSJ, CNBC, NYT, The Globe & Mail, The Deal, and virtually every other major financial media outlet.
PropThink is an intelligence service that delivers long and short trading ideas to investors in the healthcare and life sciences sectors. Our Editorial Team is comprised of individuals with a strong background in science, medicine and the business of successfully commercializing therapeutics, medical devices, diagnostics and healthcare services. Our ultimate objective is to leverage the knowledge, experience, and relationships of our contributors to introduce our subscribers to profitable long and short investment opportunities in the healthcare sector.
Successfully trading, and investing in emerging growth healthcare companies is a difficult task. Over 90% of drugs never make it out of the clinic. Huge capital requirements along the way result in highly dilutive equity financings often done on the backs of retail investors. At PropThink, we believe that due diligence is the key to success in this industry. We leverage a combined 50 years of experience in science, medicine, legal, regulatory affairs, finance, and operational industry experience to analyze companies at a highly technical level. This detailed analysis and due diligence process defines our editorial strategy and provides our subscribers a high level of confidence in our research. Our focus is on identifying and analyzing technically-complicated companies and equities that are grossly over or under-valued.
Visit PropThink.com to see all of our coverage and research, and subscribe to our free newsletter to receive reports, articles, and trading alerts.
I'm the author of six published books, an investor, and a cancer survivor. I got my start thirty-two years ago ghost-writing for a UCLA econ. prof who owned a popular stock-picking newsletter. I have been extensively involved in clinical research (consulted with various medical colleges on new technologies) as well as a speaker in post-doctoral continuing ed in the US, UK, and Canada. Right now, I'm re-editing books for publication and writing articles on Seeking Alpha for others who (like me) enjoy doing extensive investment research and profiting from it.
I founded Seeking Alpha, and lead it for its first 10 years until I passed the CEO role to Eli Hoffmann. I started Seeking Alpha after working for five years as a technology research analyst for Morgan Stanley in New York. Seeking Alpha is now the dominant crowdsourced equity research platform.
I wrote the ETF Investment Guide (http://seekingalpha.com/article/15136-etf-investing-guide-one-page-summary-of-the-entire-guide), and I blog about startup best practices at http://davidjaxon.wordpress.com .
I have a B.A from Oxford University and an MSc from The London School of Economics, and am married with five children.
I focus on writing about individual stocks, frequently in the financial industry. I work as a mid-level executive in the insurance industry on the portfolio management side. I'm an experienced stock investor, and I'm eager to share my industry expertise and what I've learned about investing with other Seeking Alpha users.
Ronnie Moas is the Founder & Director of Research at Standpoint Research and Founder of www.philanthropyandphilosophy.com. Ronnie has given more than 50 television, radio, magazine and newspaper interviews in the last year and was recently ranked # 1 versus 3,795 analysts at TipRanks. Standpoint Research currently advises and sells its research to pension funds, hedge funds, day-traders and asset management firms. Mr. Moas spent 1998-2003 developing and back-testing a 155-variable equity valuation and diagnostic model. The model has been run more than 1000 times since development was completed in June 2003. The model has since then built an exceptional track record of more than 800 recommendations. In 2002, he wrote a 284-page research report back-testing more than one-dozen different trading strategies on 20 years of data. In 2003, Mr. Moas was one of the first analysts on Wall Street to forecast bull markets in commodities, Brazil, Russia, India and China. He also exited (mid-2007) and re-entered (late-2008) in a timely manner. Ronnie has issued more than 800 stock recommendations since July 2003. Standpoint Research is ranked # 1 beating the S&P-500 by at least 500 bps with 67% of their (494) recommendations (2008-2015). Bloomberg and Dow Jones have both time-stamped all recommendations made by Standpoint Research since 2008. Ideas are generated by a 155-variable computer model Ronnie developed (1998-2003). Recommendations are made only after heavy fundamental and subjective overlays are applied. Standpoint Research covers all ten sectors. Standpoint Research is now widely recognized as one of the top equity research firms in the US and internationally. Ronnie has made multiple appearances on Bloomberg, Fox and CNBC and is quoted frequently in The Wall St. Journal, Fortune magazine, The New York Times, BusinessWeek, and Barron’s (among many others). Mr. Moas received a Bachelor’s degree in Economics and Business with Honors from the State University of New York at Stony Brook, and a Masters degree in Finance and Investments from Baruch College, City University of New York. Mr. Moas was born in New York and lived in Israel from 1983-1994. He returned to New York after completing a three-year Israeli military service in artillery and intelligence with rank of Sergeant. Before returning to the United States in 1994, Ronnie worked at Shuki Weiss International Concert Productions where a few of his production credits included the Haifa Seaport Blues Festival, Bob Dylan, Radiohead, Buddy Guy and Suede. Ronnie has traveled to more than 50 countries on six continents since 2007, he designed the Standpoint Research web site, is the owner of an articulate African Grey Parrot and a very large music collection of 1,500 cds.
I have been an active investor for almost 20 years. My main focus is on high-yield stocks, particularly MLPs, and high-growth oil companies in the Eagle Ford shale. I have a portion of my portfolio allocated to short-term trading, with a focus on over-reactions to company news and directional plays on VIX-based ETFs. I am happy to answer just about any question sent my way, especially from those new to the stock market.